Metraipolis › archive › dc_739a0ccdbc8a

Synergistic toxicity and clinical prioritization of docetaxel combined with nintedanib for non-small cell lung cancer: a real-world safety analysis using the… — Europe PMC PMID:42577017

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42577017
DOI: 10.3389/fonc.2026.1836198
License (as archived): solo-consultazione
Archived: 2026-10-08T17:09:05.962Z
SHA-256 of the archived text: 4aab8fefff030f6a865e377dcfe2b66e02cafeeb67d2bbe1624df80f08a3c683
Stable URL of this page: https://metraipolis.com/documento/dc_739a0ccdbc8a

How to cite

Synergistic toxicity and clinical prioritization of docetaxel combined with nintedanib for non-small cell lung cancer: a real-world safety analysis using the… — Europe PMC PMID:42577017 — Europe PMC (en), https://europepmc.org/article/MED/42577017 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_739a0ccdbc8a (Metraipolis archive dc_739a0ccdbc8a, sha256 4aab8fefff030f6a865e377dcfe2b66e02cafeeb67d2bbe1624df80f08a3c683)

BibTeX

@misc{dc739a0ccdbc8a,
  title = {Synergistic toxicity and clinical prioritization of docetaxel combined with nintedanib for non-small cell lung cancer: a real-world safety analysis using the… — Europe PMC PMID:42577017},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42577017},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_739a0ccdbc8a; sha256 4aab8fefff030f6a865e377dcfe2b66e02cafeeb67d2bbe1624df80f08a3c683},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42577017. Agents can read the archived copy with the MCP tool read_document.